核黄素市场：按来源、形式、应用、地区 - 规模、份额、前景、机会分析，2022-2030

核黄素是一种维生素 B，由微生物合成。过去，它是由生产过剩率很高的微生物製成的。人体可在肠道内合成少量核黄素，但不足以满足营养需求。它是帮助细胞生长和产生能量的辅□的组成部分之一。它还有助于脂肪、类固醇和药物的分解。过量的膳食核黄素会从尿液中排出。

市场动态

强化食品和饮料不断增长的需求以及核黄素的广泛应用正在推动核黄素市场的增长。此外，越来越多地使用植物性食品和饮料也有望推动市场增长。此外，扩大在宠物食品补充剂中的使用也有望推动市场增长。

另一方面，高价格和低湿度稳定性预计将成为限制市场增长的主要因素。

本研究的主要特点

• 本报告对全球核黄素市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%)。
• 解释不同细分市场的潜在收入机会，并描述该市场具有吸引力的投资建议矩阵。
• 它还提供了重要的见解，包括市场驱动因素和限制、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略。
• 根据公司亮点、产品组合、关键亮点、财务业绩和战略等参数，介绍了全球核黄素市场主要参与者的概况。
• 本研究涵盖的主要公司包括 BASF SE、Koninklijke DSM NV、上海 Acebright Pharmaceuticals Group Co. Ltd、Xinfa Pharmaceutical Co. Ltd、湖北广济製药 Co. Ltd、NB Group Co. Ltd、Hegno、Legend Industries , 和河北圣雪大成药业有限公司。
• 此报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。看起来。
• 全球核黄素市场报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球核黄素市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场快照：按来源
  • 市场概况：按格式
  • 市场快照：按应用
  • 市场概况：按地区划分
• 连贯的机会图 (COM)

第 3 章市场动态、监管和趋势分析

• 市场动态
  • 对营养丰富的食品和饮料的需求不断扩大
  • 核黄素对湿度和光线很敏感。
  • 对植物性食品和饮料的需求不断扩大
• 影响分析
• 主要亮点
• 监管场景
• 产品发布和批准
• PEST 分析
• PORTER 分析
• 併购方案

第 4 章全球核黄素市场 - 冠状病毒 (COVID-19) 大流行的影响

• COVID-19 的流行病学特征
• 供应方和需求方分析
• 经济影响

第 5 章按来源分列的全球核黄素市场，2017-2030

• 化学合成
• 发酵

第 6 章按形式分列的全球核黄素市场，2017-2030

• 粉末
• 液体

第 7 章按应用分列的全球核黄素市场，2017-2030

• 食物和饮料
• 膳食补充剂
• 药品
• 动物饲料
• 个人护理
• 其他用途

第 8 章按地区分列的全球核黄素市场，2017-2030 年

• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲
• 世界其他地区

第 9 章竞争格局

• BASF SE
• Koninklijke DSM NV
• Shanghai Acebright Pharmaceuticals Group Co. Ltd
• Xinfa Pharmaceutical Co. Ltd
• Hubei Guangji Pharmaceutical Co. Ltd
• NB Group Co. Ltd
• Hegno
• Legend Industries
• Hebei Shengxue dacheng Pharmaceutical Co. Ltd

第 10 章

• 调查方法介绍
• 关于出版商

Riboflavin is a type of vitamin B. It is synthesized by microorganisms. In the past, it was made by microorganisms that had a high rate of overproduction. The human body can synthesize riboflavin in small amounts in the gut but cannot make enough to fulfill its nutritional requirements. It is one of the components of coenzymes that aid in cell growth and energy production. It also contributes to the breakdown of fats, steroids, and medications. Excess dietary riboflavin is excreted in urine.

Market Dynamics:

Growing demand from fortified food &beverage and wide-application of riboflavin are driving growth of the riboflavin market. Moreover, increasing for plant-based food and beverages is again anticipated to foster market growth. Furthermore, expanding scope in pet food supplements is further anticipated to foster market growth.

On the contrary, high price and low stability on exposure to humidity are key factors expected to restrict the market growth.

Key features of the study:

• This report provides in-depth analysis of the global riboflavin market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global riboflavin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include BASF SE, Koninklijke DSM NV, Shanghai Acebright Pharmaceuticals Group Co. Ltd, Xinfa Pharmaceutical Co. Ltd, Hubei Guangji Pharmaceutical Co. Ltd, NB Group Co. Ltd, Hegno, Legend Industries, and Hebei Shengxue dacheng Pharmaceutical Co. Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global riboflavin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global riboflavin market

Detailed Segmentation:

• Global Riboflavin Market, By Source:
  • Chemical Synthesis
  • Fermentation
• Global Riboflavin Market, By Form:
  • Powder
  • Liquid
• Global Riboflavin Market, By Application:
  • Food and Beverages
  • Dietary Supplements
  • Pharmaceutical
  • Animal Feed
  • Personal Care
  • Other Applications
• Global Riboflavin Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Source
  • Market Snapshot, By Form
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing demand from fortified food &beverages
  • Sensitivity of riboflavin toward humidity and light
  • Growing demand for plant-based food &beverages
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Riboflavin Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Riboflavin Market, By Source, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Chemical Synthesis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Fermentation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Riboflavin Market, By Form, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Powder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Liquid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Riboflavin Market, By Application, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Food and Beverages
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Dietary Supplements
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Pharmaceutical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Animal Feed
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Personal Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
• Other Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Riboflavin Market, By Region, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2017-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

9. Competitive Landscape

• BASF SE
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Koninklijke DSM NV
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Shanghai Acebright Pharmaceuticals Group Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Xinfa Pharmaceutical Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hubei Guangji Pharmaceutical Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NB Group Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hegno
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Legend Industries
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hebei Shengxue dacheng Pharmaceutical Co. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us